TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BYND

Beyond Meat Inc

Consumer Defensive · Packaged Foods · listed since 2019

11.70$ +6.8% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

Why this colour

Red here stands for a documented risk to the substance of the business, not for a judgment on price. Four findings support it together: negative equity of $21.1 million as of March 28, 2026; interest coverage clearly below one ($6.7 million of interest expense against a $41.1 million quarterly operating loss) on debt that keeps growing through payment-in-kind interest of 9.5 and 12.0 percent; two unremediated material weaknesses alongside disclosure controls explicitly classified as not effective; and a listing risk the company itself names in connection with the Nasdaq minimum bid price requirement. Deliberately excluded from this verdict are the low share price and the high volatility — those are price arguments. Honesty also requires the other side: there is no going-concern warning from the auditors, cash stood at $191.0 million on March 28, 2026, covenants were met, and cash burn has fallen to a fifth of the prior-year level. Anyone watching this stock should check three lines in the next quarterly report: equity, cash from operations and the share count on the cover page. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

Beyond Meat is the anchoring trap in its purest form: today's price cannot be compared with the 2019 price, because a note exchange sits between them that turned 76 million shares into more than 500 million. The only annual profit in company history (2025: $219.0 million) consists of $548.7 million of book gain, while operations lost $333.6 million and burned $144.9 million. The cost side demonstrably works better — $5.0 million of cash burn in the first quarter of 2026 instead of $26.1 million, and a gross margin back in positive territory — yet revenue has fallen for four years, equity is below zero, and interest is paid in paper. Not investment advice.

Earnings quality

The only annual profit in company history is an accounting entry: $219.0 million of net income in 2025, of which $548.7 million came from debt restructuring, against a $333.6 million operating loss and $144.9 million of cash used in operations. 2024 (−$160.3 million) and 2023 (−$338.1 million) were losses as well.

Balance sheet & financing

Equity stood at negative $21.1 million as of March 28, 2026. Interest is paid in paper — 9.50 percent PIK on the 2030 notes, 12.0 percent (14.3 effective) on the first-lien term loan — so the debt keeps growing: by $10.4 million on May 1, 2026 alone. With a $41.1 million quarterly operating loss against $6.7 million of interest expense, interest coverage is clearly below one.

Dilution

76,065,969 shares (December 31, 2024) became 515,342,392 (May 6, 2026), 317,834,446 of them from the October 2025 note exchange. Another 165,689,333 instruments are potentially dilutive, against three billion authorized shares. Any recovery above the $1.7459 conversion price automatically brings new stock with it.

Cost discipline

Cash used in operating activities fell to $5.0 million in the first quarter of 2026 from $26.1 million a year earlier, the gross margin swung from negative 10.1 percent to positive 3.4 percent, and research and administrative costs dropped by double digits. That movement comes from operations, not from accounting.

Demand & market position

Revenue has fallen for four years — from $464.7 million (2021) to $275.5 million (2025), down 15.6 percent in 2025 alone on 15.9 percent lower volume; the first quarter of 2026 was down 15.3 percent. Net revenue per pound actually rose slightly: this is a volume problem, not a price problem.

Reporting quality & controls

Two material weaknesses in internal control were unremediated as of March 28, 2026 — one covering non-routine and complex transactions, the other inventory valuation. The chief executive and chief financial officers explicitly classified disclosure controls as "not effective," and the late 2025 annual report drew a Nasdaq deficiency notice on April 6, 2026.

Worth Noting

Beyond Meat reached our research list through the daily review of mandatory SEC filings: the Form 8-K of April 9, 2026 (Item 3.01) reported a Nasdaq deficiency notice for the late 2025 annual report. It is not a momentum or value scanner hit — conventional ratios mislead here, because the 2025 "profit" is a book gain and book value is negative.

Recency status: we evaluated the Form 10-K for 2025 (filed April 9, 2026) and the Form 10-Q for the quarter ended March 28, 2026 (filed May 7, 2026) plus every filing made since — among them the Big Geyser warrants (8-K of June 25, 2026), the indenture amendment discussions (8-K of July 17, 2026) and the appointment of a chief operating officer (8-K of July 30, 2026). The share count comes from the 10-Q cover page (as of May 6, 2026).

Valuation figures are dated and evergreen: market capitalization of roughly $0.33 billion based on 515,342,392 shares and a price in the $0.60 to $0.65 range (data as of August 5, 2026); the cross-check is the $0.60 warrant exercise price documented in the 8-K of June 25, 2026. Not to be confused: the reported 2025 net income is not an operating profit, and no going-concern warning from the auditors exists.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at BYND since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 0.407 $ to 14.80 $ · Last price: 11.70 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.2$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 17m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 96.9%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 2.8

Performance

Perf. 1M ?Price performance over the last month. -13.60%
Perf. 3M ?Price performance over the last 3 months. -32.50%
Perf. 6M ?Price performance over the last 6 months. -13.50%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -22.68%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -82.5%
Perf. 1Y ?Price performance over the last 12 months. -85.71%
Perf. 3Y ?Price performance over the last 3 years. -96.23%
Perf. 5Y ?Price performance over the last 5 years. -99.65%
Perf. Since Inception ?Price performance since the first available trading day (05/02/2019) — with a complete history, that is since the IPO. -99.41%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 8.00$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 6.20$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 2.20$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 61.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 114.6%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 191.3%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 5,000.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey. 40.7
P/B ?Price-to-book ratio: market value relative to book equity. 1,125.3
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 0.7
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. 1.2
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. 10.3%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes. -69.3%
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 115.9%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -1,167.0%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -15.5%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet. very low -0.02%
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone -2.29
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 3 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). -15.30%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -15.61%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. -76.18%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee. 80.80%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 5
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 42
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. C (48 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Packaged Foods

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Beyond Meat Inc BYND 0.2 1.2 10.3 -69.3 -15.6 -85.7
JBS N.V. JBS 39.9 11.7 6.2 11.8 2.5 13.0 -16.1
Kraft Heinz Co KHC 29.1 13.1 33.5 20.7 -3.5 2.7
General Mills Inc GIS 19.9 9.2 21.6 33.7 19.2 -1.9 -20.8
McCormick & Company Incorporated MKC-V 13.8 8.6 13.4 38.9 17.4 1.7 -18.7
McCormick & Company Incorporated MKC 13.5 8.9 13.1 38.9 17.4 1.7 -23.2
The J. M. Smucker Company SJM 12.8 14.8 38.0 18.5 3.7 22.5
Hormel Foods Corporation HRL 11.6 28.1 15.5 15.7 11.1 1.6 -12.2
Darling Ingredients Inc DAR 10.7 48.5 9.6 26.3 8.1 7.4 100.8
Median of companies shown 13.5 10.4 13.1 33.5 17.4 1.7 -16.1

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 16 $M 2016 · Operating income: -25 $M 2016 · Net income: -25 $M 2017 · Revenue: 33 $M 2017 · Operating income: -29 $M 2017 · Net income: -30 $M 2018 · Revenue: 88 $M 2018 · Operating income: -28 $M 2018 · Net income: -30 $M 2019 · Revenue: 298 $M 2019 · Operating income: 0 $M 2019 · Net income: -12 $M 2020 · Revenue: 407 $M 2020 · Operating income: -49 $M 2020 · Net income: -53 $M 2021 · Revenue: 465 $M 2021 · Operating income: -175 $M 2021 · Net income: -182 $M 2022 · Revenue: 419 $M 2022 · Operating income: -343 $M 2022 · Net income: -366 $M 2023 · Revenue: 343 $M 2023 · Operating income: -342 $M 2023 · Net income: -338 $M 2024 · Revenue: 326 $M 2024 · Operating income: -156 $M 2024 · Net income: -160 $M 2025 · Revenue: 276 $M 2025 · Operating income: -233 $M 2025 · Net income: 220 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 16 -25 -25 -16.27 -24 -67 35
2017 33 -29 -30 -19.66 -25 -96 66
2018 88 -28 -30 -19.34 -38 79 134
2019 298 0 -12 -8.83 -47 384 452
2020 407 -49 -53 -25.41 -40 367 468
2021 465 -175 -182 -86.48 -301 133 1,379
2022 419 -343 -366 -172.65 -320 -204 1,062
2023 343 -342 -338 -157.77 -108 -513 774
2024 326 -156 -160 -72.85 -99 -601 678
2025 276 -233 220 36.38 -161 0 616

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q2 · 93.2 $M Q2 2024: Q3 · 81.0 $M Q3 2024: Q4 · 76.7 $M Q4 2025: Q1 · 68.7 $M Q1 2025: Q2 · 75.0 $M Q2 2025: Q3 · 70.2 $M Q3 2025: Q4 · 61.6 $M Q4 2026: Q1 · 58.2 $M Q1 2026: Q2 · 68.8 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q2 -0.53 36.10 93 -8.80 -37.00 -16 -17
2024: Q3 -0.41 62.40 81 7.60 -32.80 -22 -24
2024: Q4 -0.65 29.30 77 4.00 -58.50 -29 -35
2025: Q1 -0.80 4.80 69 -9.10 -77.00 -26 -31
2025: Q2 -0.40 24.50 75 -19.60 -39.00 -33 -35
2025: Q3 -0.47 -14.60 70 -13.30 -157.60 -39 -42
2025: Q4 -0.39 39.50 62 -19.70 670.20 -52 -61
2026: Q1 -0.10 87.50 58 -15.30 -48.90 -5 -8
2026: Q2 -0.06 85.00 69 -8.30 23.80 -18 -20

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 13 of our scanner strategies — each hit links to the scanner.

Growth

Momentum & Trend

Research

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Buy 1 = Strong buy … 5 = Strong sell
Analyst Ratings 10
Price Target (average) 12.50$
Distance to price 6.8% The price target sits 6.8% above the current price.

Distribution of Recommendations

Strong Buy 0
Buy 0
Hold 5
Sell 2
Strong Sell 3

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -11.83 -13.76 – -9.90 246 77.7% 2
12/31/2027 -10.42 -12.57 – -8.28 242 11.9% 2

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Neutral

Kein wesentlicher KI-Bezug in den sechs ausgewerteten Filings: Beyond Meat verkauft keine KI-Produkte, belegt keinen operativen KI-Einsatz und nennt KI nur als allgemeinen Technologietrend in den Risikofaktoren — reine Boilerplate ohne konkreten Bezug zum eigenen Geschäftsmodell.

View the full file — quotes, sources, reviewed filings
„Emerging technological trends such as artificial intelligence, machine learning and automation are impacting industries and business operations. If we do not sufficiently invest in new technology and industry developments, appropriately implement new technologies or evolve our business at sufficient speed and scale in response to such developments, or if we do not make the right strategic investments to respond to these developments, our products, results of operations and ability to develop and maintain our business could be negatively affected."

Aufkommende Technologietrends wie künstliche Intelligenz, maschinelles Lernen und Automatisierung wirken auf Branchen und Geschäftsabläufe ein. Wenn wir nicht ausreichend in neue Technologien und Branchenentwicklungen investieren, neue Technologien nicht angemessen einführen oder unser Geschäft nicht schnell und umfassend genug an diese Entwicklungen anpassen, oder wenn wir nicht die richtigen strategischen Investitionen als Antwort auf diese Entwicklungen tätigen, könnten unsere Produkte, unsere Geschäftsergebnisse und unsere Fähigkeit, unser Geschäft zu entwickeln und zu erhalten, beeinträchtigt werden.

10-K · 2026-04-09 · View SEC filing

„… commercialization and scale-up of new products, the success of our management and sales and marketing teams in introducing and marketing new products, our ability to adapt to changes in technology, including the successful utilization of data analytics, artificial intelligence and machine learning, managing the distribution of new products and managing our partnerships with distributors in a product category that we have limited experience with."

… Kommerzialisierung und Hochlauf neuer Produkte, der Erfolg unserer Führungs-, Vertriebs- und Marketingteams bei der Einführung und Vermarktung neuer Produkte, unsere Fähigkeit, uns an technologische Veränderungen anzupassen — einschließlich der erfolgreichen Nutzung von Datenanalyse, künstlicher Intelligenz und maschinellem Lernen —, die Steuerung des Vertriebs neuer Produkte und die Steuerung unserer Partnerschaften mit Händlern in einer Produktkategorie, mit der wir nur begrenzte Erfahrung haben.

10-Q · 2026-05-07 · View SEC filing

Filings Reviewed: 10-Q 2026-05-07 · 10-K 2026-04-09 · 10-Q 2025-11-12 · 10-Q 2025-08-08 · 10-Q 2025-05-08 · 10-K 2025-03-05

Rated on August 5, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

2 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years -13.0%
  • More than 10% revenue growth is expected for the coming year -76.2%
  • Share count grows by less than 3% a year 41.8%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -78.4%
  • Gross margin at 40% or higher and without meaningful erosion 2.8%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 1.1 x EBITDA
  • Operating cash flow covers the profits of the last three years -89 m
  • Return on capital at 15% or higher, or up versus two years ago -43.2%
  • Insiders hold at least 10% or are net buyers 3.4%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

1/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% 37.0%
  • Exp. sales growth 3Y > 5% -6.2%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5% -6.2%
  • Net debt < 4x EBIT
  • EBIT positive, 10Y straight 0
  • Max. EBIT decline < 50%
  • Return on equity > 15%
  • ROCE > 15% -43.2%
  • Expected return > 10% -92.9%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 14, 2026 Kutua Lubi CFO, Treasurer Other 119 10.31 1,227
Sep 14, 2026 Brown Ethan President, Chief Exec. Officer Other 421 10.31 4,341
Sep 14, 2026 Ajami Dariush Chief Innovation Officer Other 102 10.31 1,052
Sep 14, 2026 Witteman Teri L Chief Legal Officer, Secretary Other 68 10.31 701
Jul 13, 2026 Kutua Lubi CFO, Treasurer Other 1,209 0.6211 751
Jul 10, 2026 Lufkin Paul Andrew Senior Vice President, Sales Other 1,107 0.656 726
Apr 20, 2026 Teri L Witteman Insider Sell 29,978 1.00 29,978

View all insider transactions →

The company

About the Company

Beyond Meat, Inc., a plant-based meat company, engages in the development, manufacture, marketing, and sale of plant-based meat products under the Beyond brand name in the United States and internationally. The company sells a range of plant-based meat products that replicates beef, pork, and poultry meats. It sells its products through grocery, mass merchandiser, club stores, and natural retailer channels, as well as various food-away-from-home channels, including restaurants, foodservice outlets, and schools. The company was formerly known as Savage River, Inc. and changed its name to Beyond Meat, Inc. in September 2018. Beyond Meat, Inc. was incorporated in 2008 and is headquartered in El Segundo, California.

Employees
589
Headquarters
El Segundo, CA
Address
888 North Douglas Street, 90245 El Segundo, United States
Phone
866 756 4112
IPO Date
05/02/2019
ISIN
US08862E1091
Stock Split
1:30 on 08/14/2026

Management

Management
Name Title Birth Year
Ethan Brown Founder, President, CEO & Director 1972
Lubi Kutua CFO & Treasurer 1982
Teri L. Witteman Esq., J.D. Chief Legal Officer & Secretary 1968
Drew Lufkin Senior Vice President of Sales 1978
Dariush Ajami Ph.D. Chief Innovation Officer 1976
Brijesh Krishnaswamy Chief Operating Officer 1974
Tony T. Kalajian CPA, M.B.A. Chief Accounting Officer 1971
Paul Sheppard Vice President of Financial Planning & Analysis and Investor Relations
Shira Zackai Head of Communications & VP
John R. Boken Interim Chief Transformation Officer 1963

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 09/01/2026 BEYOND MEAT, INC. (BYND): Other Events SEC ↗
  • 08/14/2026 BEYOND MEAT, INC. (BYND): Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events; Financial Statements and Exhibits SEC ↗
  • 08/11/2026 BEYOND MEAT, INC. (BYND): Other Events; Financial Statements and Exhibits SEC ↗
  • 08/10/2026 BEYOND MEAT, INC. (BYND): Entry into a Material Definitive Agreement; Financial Statements and Exhibits SEC ↗
  • 08/05/2026 BEYOND MEAT, INC. (BYND): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/30/2026 BEYOND MEAT, INC. (BYND): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 07/17/2026 BEYOND MEAT, INC. (BYND): Regulation FD Disclosure SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?